Cultural Adaptation and Validation of the EORTC QLQ-BR45 to Assess Health-Related Quality of Life of Breast Cancer Patients

[1] Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians 2018, 68(6):394–424. BrayF FerlayJ SoerjomataramI SiegelRL TorreLA JemalA Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA: a cancer journal for clinicians 2018 68 6 394 424 10.3322/caac.21492 Search in Google Scholar

[2] Mokhatri-Hesari P, Montazeri A: Health-related quality of life in breast cancer patients: review of reviews from 2008 to 2018. Health Qual Life Outcomes 2020, 18(1):338. Mokhatri-HesariP MontazeriA Health-related quality of life in breast cancer patients: review of reviews from 2008 to 2018 Health Qual Life Outcomes 2020 18 1 338 10.1186/s12955-020-01591-x Search in Google Scholar

[3] Bonnetain F, Borg C, Adams RR, Ajani JA, Benson A, Bleiberg H, Chibaudel B, Diaz-Rubio E, Douillard JY, Fuchs CS et al: How health-related quality of life assessment should be used in advanced colorectal cancer clinical trials. Annals of oncology : official journal of the European Society for Medical Oncology 2017, 28(9):2077–2085. BonnetainF BorgC AdamsRR AjaniJA BensonA BleibergH ChibaudelB Diaz-RubioE DouillardJY FuchsCS How health-related quality of life assessment should be used in advanced colorectal cancer clinical trials Annals of oncology : official journal of the European Society for Medical Oncology 2017 28 9 2077 2085 10.1093/annonc/mdx191 Search in Google Scholar

[4] Velikova G, Coens C, Efficace F, Greimel E, Groenvold M, Johnson C, Singer S, van de Poll-Franse L, Young T, Bottomley A: Health-Related Quality of Life in EORTC clinical trials — 30 years of progress from methodological developments to making a real impact on oncology practice. European Journal of Cancer Supplements 2012, 10(1):141–149. VelikovaG CoensC EfficaceF GreimelE GroenvoldM JohnsonC SingerS van de Poll-FranseL YoungT BottomleyA Health-Related Quality of Life in EORTC clinical trials — 30 years of progress from methodological developments to making a real impact on oncology practice European Journal of Cancer Supplements 2012 10 1 141 149 10.1016/S1359-6349(12)70023-X Search in Google Scholar

[5] EORTC. EORTC QLQ-C30 (Version 3). EORTC Study Group on Quality of Life. 1995 [https://qol.eortc.org/] EORTC EORTC QLQ-C30 (Version 3) EORTC Study Group on Quality of Life 1995 [https://qol.eortc.org/] Search in Google Scholar

[6] EORTC. EORTC QLQ-BR23. (version 1). EORTC Study Group on Quality of Life. 1994 [https://qol.eortc.org/] EORTC EORTC QLQ-BR23. (version 1) EORTC Study Group on Quality of Life 1994 [https://qol.eortc.org/] Search in Google Scholar

[7] Perez EA: Safety profiles of tamoxifen and the aromatase inhibitors in adjuvant therapy of hormone-responsive early breast cancer. Annals of Oncology 2007, 18:viii26–viii35. PerezEA Safety profiles of tamoxifen and the aromatase inhibitors in adjuvant therapy of hormone-responsive early breast cancer Annals of Oncology 2007 18 viii26 viii35 10.1093/annonc/mdm263 Search in Google Scholar

[8] van Nes JGH, Fontein DBY, Hille ETM, Voskuil DW, van Leeuwen FE, de Haes JCJM, Putter H, Seynaeve C, Nortier JWR, van de Velde CJH: Quality of life in relation to tamoxifen or exemestane treatment in postmenopausal breast cancer patients: a Tamoxifen Exemestane Adjuvant Multinational (TEAM) Trial side study. Breast Cancer Research and Treatment 2012, 134(1):267–276. van NesJGH FonteinDBY HilleETM VoskuilDW van LeeuwenFE de HaesJCJM PutterH SeynaeveC NortierJWR van de VeldeCJH Quality of life in relation to tamoxifen or exemestane treatment in postmenopausal breast cancer patients: a Tamoxifen Exemestane Adjuvant Multinational (TEAM) Trial side study Breast Cancer Research and Treatment 2012 134 1 267 276 10.1007/s10549-012-2028-2 Search in Google Scholar

[9] Gianni L, Dafni U, Gelber RD, Azambuja E, Muehlbauer S, Goldhirsch A, Untch M, Smith I, Baselga J, Jackisch C et al: Treatment with trastuzumab for 1 year after adjuvant chemotherapy in patients with HER2-positive early breast cancer: a 4-year follow-up of a randomised controlled trial. The Lancet Oncology 2011, 12(3):236–244. GianniL DafniU GelberRD AzambujaE MuehlbauerS GoldhirschA UntchM SmithI BaselgaJ JackischC Treatment with trastuzumab for 1 year after adjuvant chemotherapy in patients with HER2-positive early breast cancer: a 4-year follow-up of a randomised controlled trial The Lancet Oncology 2011 12 3 236 244 10.1016/S1470-2045(11)70033-X Search in Google Scholar

[10] Harbeck N, Iyer S, Turner N, Cristofanilli M, Ro J, André F, Loi S, Verma S, Iwata H, Bhattacharyya H et al: Quality of life with palbociclib plus fulvestrant in previously treated hormone receptor-positive, HER2-negative metastatic breast cancer: patient-reported outcomes from the PALOMA-3 trial. Annals of Oncology 2016, 27(6):1047–1054. HarbeckN IyerS TurnerN CristofanilliM RoJ AndréF LoiS VermaS IwataH BhattacharyyaH Quality of life with palbociclib plus fulvestrant in previously treated hormone receptor-positive, HER2-negative metastatic breast cancer: patient-reported outcomes from the PALOMA-3 trial Annals of Oncology 2016 27 6 1047 1054 10.1093/annonc/mdw139488006527029704 Search in Google Scholar

[11] Winters ZE, Afzal M, Rutherford C, Holzner B, Rumpold G, da Costa Vieira RA, Hartup S, Flitcroft K, Bjelic-Radisic V, Oberguggenberger A et al: International validation of the European Organisation for Research and Treatment of Cancer QLQ-BRECON23 quality-of-life questionnaire for women undergoing breast reconstruction. British Journal of Surgery 2018, 105(3):209–222. WintersZE AfzalM RutherfordC HolznerB RumpoldG da Costa VieiraRA HartupS FlitcroftK Bjelic-RadisicV OberguggenbergerA International validation of the European Organisation for Research and Treatment of Cancer QLQ-BRECON23 quality-of-life questionnaire for women undergoing breast reconstruction British Journal of Surgery 2018 105 3 209 222 10.1002/bjs.1065629116657 Search in Google Scholar

[12] Bjelic-Radisic V, Cardoso F, Cameron D, Brain E, Kuljanic K, da Costa RA, Conroy T, Inwald EC, Serpentini S, Pinto M et al: An international update of the EORTC questionnaire for assessing quality of life in breast cancer patients: EORTC QLQ-BR45. Annals of oncology : official journal of the European Society for Medical Oncology 2020, 31(2):283–288. Bjelic-RadisicV CardosoF CameronD BrainE KuljanicK da CostaRA ConroyT InwaldEC SerpentiniS PintoM An international update of the EORTC questionnaire for assessing quality of life in breast cancer patients: EORTC QLQ-BR45 Annals of oncology : official journal of the European Society for Medical Oncology 2020 31 2 283 288 10.1093/annonc/mdy270.267 Search in Google Scholar

[13] Raosoft sample size calculator [http://www.raosoft.com/samplesize.html] Raosoft sample size calculator [http://www.raosoft.com/samplesize.html] Search in Google Scholar

[14] EORTC. EORTC Scoring Manual (Third Edition). 2001 [https://www.eortc.org/] EORTC EORTC Scoring Manual (Third Edition) 2001 [https://www.eortc.org/] Search in Google Scholar

[15] Eortc Quality Of Life Group Translation Procedure, Fourth edition [https://www.eortc.org/app/uploads/sites/2/2018/02/translation_manual_2017.pdf] Eortc Quality Of Life Group Translation Procedure Fourth edition [https://www.eortc.org/app/uploads/sites/2/2018/02/translation_manual_2017.pdf] Search in Google Scholar

[16] Beaton DE, Bombardier C, Guillemin F, Ferraz MB: Guidelines for the process of cross-cultural adaptation of self-report measures. Spine 2000, 25(24):3186–3191. BeatonDE BombardierC GuilleminF FerrazMB Guidelines for the process of cross-cultural adaptation of self-report measures Spine 2000 25 24 3186 3191 10.1097/00007632-200012150-0001411124735 Search in Google Scholar

[17] Sprangers MA, Groenvold M, Arraras JI, Franklin J, te Velde A, Muller M, Franzini L, Williams A, de Haes HC, Hopwood P et al: The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study. J Clin Oncol 1996, 14(10):2756–2768. SprangersMA GroenvoldM ArrarasJI FranklinJ te VeldeA MullerM FranziniL WilliamsA de HaesHC HopwoodP The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study J Clin Oncol 1996 14 10 2756 2768 10.1200/JCO.1996.14.10.27568874337 Search in Google Scholar

[18] Cronbach LJJp: Coefficient alpha and the internal structure of tests. 1951, 16(3):297–334. CronbachLJJp Coefficient alpha and the internal structure of tests 1951 16 3 297 334 10.1007/BF02310555 Search in Google Scholar

[19] El Fakir S, Abda N, Bendahhou K, Zidouh A, Bennani M, Errihani H, Benider A, Bekkali R, Nejjari C: The European Organization for Research and Treatment of Cancer quality of life questionnaire-BR23 Breast Cancer-Specific Quality of Life Questionnaire: psychometric properties in a Moroccan sample of breast cancer patients. BMC research notes 2014, 7:53. El FakirS AbdaN BendahhouK ZidouhA BennaniM ErrihaniH BeniderA BekkaliR NejjariC The European Organization for Research and Treatment of Cancer quality of life questionnaire-BR23 Breast Cancer-Specific Quality of Life Questionnaire: psychometric properties in a Moroccan sample of breast cancer patients BMC research notes 2014 7 53 10.1186/1756-0500-7-53390689324447401 Search in Google Scholar

[20] Gadisa DA, Gebremariam ET, Ali GY: Reliability and validity of Amharic version of EORTC QLQ-C30 and QLQ-BR23 modules for assessing health-related quality of life among breast cancer patients in Ethiopia. Health Qual Life Outcomes 2019, 17(1):182. GadisaDA GebremariamET AliGY Reliability and validity of Amharic version of EORTC QLQ-C30 and QLQ-BR23 modules for assessing health-related quality of life among breast cancer patients in Ethiopia Health Qual Life Outcomes 2019 17 1 182 10.1186/s12955-019-1257-z690957931830992 Search in Google Scholar

[21] Montazeri A, Harirchi I, Vahdani M, Khaleghi F, Jarvandi S, Ebrahimi M, Haji-Mahmoodi M: The EORTC breast cancer-specific quality of life questionnaire (EORTC QLQ-BR23): translation and validation study of the Iranian version. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2000, 9(2):177–184. MontazeriA HarirchiI VahdaniM KhaleghiF JarvandiS EbrahimiM Haji-MahmoodiM The EORTC breast cancer-specific quality of life questionnaire (EORTC QLQ-BR23): translation and validation study of the Iranian version Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2000 9 2 177 184 10.1023/A:1008918310251 Search in Google Scholar

[22] Cerezo O, Oñate-Ocaña LF, Arrieta-Joffe P, González-Lara F, García-Pasquel MJ, Bargalló-Rocha E, Vilar-Compte D: Validation of the Mexican-Spanish version of the EORTC QLQ-C30 and BR23 questionnaires to assess health-related quality of life in Mexican women with breast cancer. European journal of cancer care 2012, 21(5):684–691. CerezoO Oñate-OcañaLF Arrieta-JoffeP González-LaraF García-PasquelMJ Bargalló-RochaE Vilar-CompteD Validation of the Mexican-Spanish version of the EORTC QLQ-C30 and BR23 questionnaires to assess health-related quality of life in Mexican women with breast cancer European journal of cancer care 2012 21 5 684 691 10.1111/j.1365-2354.2012.01336.x22329843 Search in Google Scholar

[23] Demirci S, Eser E, Ozsaran Z, Tankisi D, Aras AB, Ozaydemir G, Anacak Y: Validation of the Turkish versions of EORTC QLQ-C30 and BR23 modules in breast cancer patients. Asian Pac J Cancer Prev 2011, 12(5):1283–1287. DemirciS EserE OzsaranZ TankisiD ArasAB OzaydemirG AnacakY Validation of the Turkish versions of EORTC QLQ-C30 and BR23 modules in breast cancer patients Asian Pac J Cancer Prev 2011 12 5 1283 1287 Search in Google Scholar

[24] Chie WC, Chang KJ, Huang CS, Kuo WH: Quality of life of breast cancer patients in Taiwan: validation of the Taiwan Chinese version of the EORTC QLQ-C30 and EORTC QLQ-BR23. Psychooncology 2003, 12(7):729–735. ChieWC ChangKJ HuangCS KuoWH Quality of life of breast cancer patients in Taiwan: validation of the Taiwan Chinese version of the EORTC QLQ-C30 and EORTC QLQ-BR23 Psychooncology 2003 12 7 729 735 10.1002/pon.72714502597 Search in Google Scholar

[25] Awad MA, Denic S, El Taji H: Validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaires for Arabic-speaking Populations. Annals of the New York Academy of Sciences 2008, 1138:146–154. AwadMA DenicS El TajiH Validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaires for Arabic-speaking Populations Annals of the New York Academy of Sciences 2008 1138 146 154 10.1196/annals.1414.02118837895 Search in Google Scholar

[26] Roshandel S, Lamyian M, Azin SA, Haghighat S, Mohammadi E: Development and validation of a guideline on sexual and reproductive health of breast cancer survivors in Iran: a mixed methods study protocol. Health Research Policy and Systems 2021, 19(1):87. RoshandelS LamyianM AzinSA HaghighatS MohammadiE Development and validation of a guideline on sexual and reproductive health of breast cancer survivors in Iran: a mixed methods study protocol Health Research Policy and Systems 2021 19 1 87 10.1186/s12961-021-00738-6816600134059055 Search in Google Scholar

[27] Mikiyas Amare G, Panpan W, Eva Johanna K, Edom S, Changying C, Adamu A: Health Qual Life Outcomes 2021. Mikiyas AmareG PanpanW Eva JohannaK EdomS ChangyingC AdamuA Health Qual Life Outcomes 2021 Search in Google Scholar

[28] Brédart A, Marrel A, Abetz-Webb L, Lasch K, Acquadro C: Interviewing to develop Patient-Reported Outcome (PRO) measures for clinical research: eliciting patients’ experience. Health Qual Life Outcomes 2014, 12:15–15. BrédartA MarrelA Abetz-WebbL LaschK AcquadroC Interviewing to develop Patient-Reported Outcome (PRO) measures for clinical research: eliciting patients’ experience Health Qual Life Outcomes 2014 12 15 15 10.1186/1477-7525-12-15393350924499454 Search in Google Scholar